Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.
Epstein-Barr virus (EBV) infection converts primary human B cells into continuously proliferating lymphoblastoid cell lines (LCLs). To examine the role of EBV nuclear antigen (EBNA) 3C in the proliferation of LCLs, we established LCLs infected with an EBV recombinant that expresses EBNA3C with a C-terminal fusion to a 4-hydroxytamoxifen (4HT)-dependent mutant estrogen receptor, E3C-HT. In the presence of 4HT, LCLs expressed the E3C-HT protein and grew like WT LCLs. When E3C-HT EBV-infected LCLs were transferred to medium without 4HT, E3C-HT protein slowly disappeared, and the LCLs gradually ceased growing. WT EBNA3C expression from an oriP plasmid transfected into E3C-HT LCLs protected the LCLs from growth arrest in medium without 4HT, whereas expression of EBNA3A or EBNA3B did not. The expression of other EBNA proteins and of LMP1, CD21, CD23, and c-myc was unaffected by EBNA3C inactivation. However, EBNA3C inactivation resulted in the accumulation of p16INK4A, a decrease in the hyperphosphorylated form of the retinoblastoma protein, and a decrease in the proportion of cells in S or G2/M phase. These results indicate that EBNA3C has an essential role in cell cycle progression and the growth maintenance of LCLs.
Maruo
Seiji
S
Department of Tumor Virology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan. smaruo@igm.hokudai.ac.jp
Wu
Yi
Y
Ishikawa
Satoko
S
Kanda
Teru
T
Iwakiri
Dai
D
Takada
Kenzo
K
D001402:B-Lymphocytes / Q000166:cytology / Q000821:virology*; D015153:Blotting, Western; D002453:Cell Cycle / Q000235:genetics / Q000502:physiology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002472:Cell Transformation, Viral / Q000235:genetics*; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism; D017931:DNA Primers; D019309:Epstein-Barr Virus Nuclear Antigens / Q000378:metabolism*; D005434:Flow Cytometry; D005816:Genetic Complementation Test; D006801:Humans; D047468:Immunoprecipitation; D016160:Retinoblastoma Protein / Q000378:metabolism; D013629:Tamoxifen / Q000031:analogs & derivatives
D019941:Cyclin-Dependent Kinase Inhibitor p16; D017931:DNA Primers; D019309:Epstein-Barr Virus Nuclear Antigens; D016160:Retinoblastoma Protein; D013629:Tamoxifen; C016601:afimoxifene